Clinical Trials Browser

Phase 2 × Endometrial Neoplasms × Erlotinib Hydrochloride × Clear all

NCT00030485 2014-01-27

Erlotinib in Treating Patients With Locally Advanced and/or Metastatic Endometrial Cancer

Phase 2 Completed

Endometrial Neoplasms